October 3, 2022
Time to buy?
“An estimated 8.4 million people were living with Type 1 Diabetes (T1D) across the globe in 2021, according to the results of a new modelling study published in The Lancet Diabetes & Endocrinology. This number is predicted to increase to 13.5-17.4 million people living with T1D by 2040.”
The question now becomes does this new model provide a real perspective or is it just another data set for every insulin pump wannabe? If it’s the later instead of the former investors will continue to use as justification for foolishly investing in these wannabes. If . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
